Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Hsu, Paula
Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
Russell, Terri
Kula, Laura
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis.
Orally administered 4-aminopyridine improves clinical signs in multiple sclerosis. Ann Neurol. 1990 Feb; 27(2):186-92.
View in:
PubMed
subject areas
4-Aminopyridine
Administration, Oral
Adult
Dose-Response Relationship, Drug
Humans
Middle Aged
Multiple Sclerosis
Reaction Time
Vision Disorders